Journals / Turkish Journal of Medical Sciences / 2020 / Cilt: 50 - Sayı: 1

Severe neonatal hyperbilirubinemia in the southeast region of Turkey

Pages
103–109
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Prevention of early hospital discharges, family education to increase awareness for hazardous effects ofhyperbilirubinemia, and early follow-up visits after discharge would reduce the disease burden.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Severe neonatal hyperbilirubinemia is an important cause of morbidity and mortality in developing countries.
📊
Key Findings & Data:Theaim was to assess etiologic reasons for development of severe hyperbilirubinemia and define risk factors for exchange transfusion andacute bilirubin encephalopathy (ABE) in Şanlıurfa located in the southeast region of Turkey.Materials and methods: An observational cohort study included 115 infants with ≥35 weeks of gestation admitted with diagnosis ofsevere hyperbilirubinemia in a period of 18 months.
💡
Conclusion & Impact:Prevention of early hospital discharges, family education to increase awareness for hazardous effects ofhyperbilirubinemia, and early follow-up visits after discharge would reduce the disease burden.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: Severe neonatal hyperbilirubinemia is an important cause of morbidity and mortality in developing countries. Theaim was to assess etiologic reasons for development of severe hyperbilirubinemia and define risk factors for exchange transfusion andacute bilirubin encephalopathy (ABE) in Şanlıurfa located in the southeast region of Turkey.Materials and methods: An observational cohort study included 115 infants with ≥35 weeks of gestation admitted with diagnosis ofsevere hyperbilirubinemia in a period of 18 months. Potential risk factors associated with exchange transfusion and development ofABE were analyzed.Results: Among 115 infants, 67 (58.3%) received exchange transfusion and 45 (39.1%) developed ABE. Rh isoimmunization (OR: 24.6,95% CI = 2.2–271, P = 0.009), glucose-6-phosphate dehydrogenase deficiency (G6PD) (OR: 21.1, 95% CI = 1.8–238.4, P = 0.01), earlydischarge (OR: 14.4, 95% CI = 4.2–48.9, P ≤ 0.001), and male sex (OR: 4.3, 95% CI = 1.3–14.1, P = 0.02) were independently associatedwith an increased risk for exchange transfusion. Being a refugee (OR: 6.8, 95% CI = 1.8–25.8, P = 0.005) and G6PD deficiency (OR: 9.9,95% CI = 1.3–71.9, P = 0.02) were associated with development of ABE.Conclusion: Early discharge, Rh isoimmunization, and G6PD deficiency are significant risk factors for severe hyperbilirubinemiaand exchange transfusion. Prevention of early hospital discharges, family education to increase awareness for hazardous effects ofhyperbilirubinemia, and early follow-up visits after discharge would reduce the disease burden.

🔖

Cite This Article

YÜCESOY, E., ATAŞ, N., PALALI, M. F., BOZKURT, Ö., AKINEL, Ö., OĞUZ, B. (2022). Severe neonatal hyperbilirubinemia in the southeast region of Turkey. Turkish Journal of Medical Sciences, Cilt: 50 - Sayı: 1, 103–109. https://ajindex.com/articles/609634

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Burke BL, Robbins JM, Bird TM, Hobbs CA, Nesmith C et al. Trends in hospitalizations for neonatal jaundice and kernicterus in the United States, 1988-2005. Pediatrics 2009; 123 (2): 524-532
  2. Battersby C, Michaelides S, Upton M, Rennie JM; Jaundice Working Group of the Atain. Term admissions to neonatal units in England: a role for transitional care? a retrospective cohort study. British Medical Journal Open 2017; 7 (5): e016050
  3. Maisels MJ, Newman TB. Kernicterus in otherwise healthy, breast-fed term newborns. Pediatrics 1995; 96 (4 Pt 1): 730- 733
  4. Hansen TW. Mechanisms of bilirubin toxicity: clinical implications. Canadian Medical Association Journal 2006; 175 (6): 587-590
  5. Sgro M, Campbell D, Shah V. Incidence and causes of severe neonatal hyperbilirubinemia in Canada. Clinics in Perinatology 2002; 29 (4): 765-778
  6. Kaplan M, Bromiker R, Hammerman C. Severe neonatal hyperbilirubinemia and kernicterus: are these still problems in the third millennium? Neonatology 2011; 100 (4): 354-362
  7. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114 (1): 297-316
  8. Bhutani VK, Vilms RJ, Hamerman-Johnson L. Universal bilirubin screening for severe neonatal hyperbilirubinemia. Journal of Perinatology 2010; 30 (Suppl.): S6-15
  9. Johnson L, Bhutani VK, Karp K, Sivieri EM, Shapiro SM. Clinical report from the pilot USA Kernicterus Registry (1992 to 2004). Journal of Perinatology 2009; 29 (Suppl. 1): S25-45
  10. Manning D, Todd P, Maxwell M, Platt MJ. Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the UK and Ireland. Archives of Disease in Childhood Fetal and Neonatal Edition 2007; 92 (5): F342-346
  11. Sgro M, Campbell D, Shah V. Incidence and causes of severe neonatal hyperbilirubinemia in Canada. Canadian Medical Association Journal 2006; 175 (6): 587-590
  12. Gamaleldin R, Iskander I, Seoud I, Aboraya H, Aravkin A et al. Risk factors for neurotoxicity in newborns with severe neonatal hyperbilirubinemia. Pediatrics 2011; 128 (4): e925-931
  13. Hameed NN, Na’ Ma AM, Vilms R, Bhutani VK. Severe neonatal hyperbilirubinemia and adverse short-term consequences in Baghdad, Iraq. Neonatology 2011; 100 (1): 57-63
  14. Iskander I, Gamaleldin R, El Houchi S, El Shenawy A, Seoud I et al. Serum bilirubin and bilirubin/albumin ratio as predictors of bilirubin encephalopathy. Pediatrics 2014; 134 (5): e1330-13